Recombinant human coagulation factor VIII for injection

recombinant human coagulation factor VIII · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Recombinant human coagulation factor VIII for injection, covering 2024-03-07 to 2026-06-12. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study of Recombinant Human Coagulation Factor VIII for Injection in Patients With Severe Hemophilia A [Phase 3]

See pricing